Anti-anxiety drugs, sleeping pills may cause death?

Image
IANS London
Last Updated : Apr 01 2014 | 2:59 PM IST

If you often pop up anti-anxiety and sleeping pills, beware! A research from the University of Warwick has found that there are linked to an increased risk of death.

The study shows that several anxiolytic (anti-anxiety) drugs or hypnotic drugs (sleeping pills) are associated with doubling the risk of mortality.

Although these findings are based on routine data and need to be interpreted cautiously, the researchers recommended that a greater understanding of their impact is essential.

Scott Weich, professor of Psychiatry at the University of Warwick, explained: "The key message here is that we really do have to use these drugs more carefully. This builds on a growing body of evidence suggesting that their side effects are significant and dangerous. We have to do everything possible to minimise over reliance on anxiolytics and sleeping pills."

The study accounted for other factors such as age, smoking and alcohol use, other prescriptions and socioeconomic status.

The study, published in the journal BMJ, tracked 34,727 people for seven-and-a-half years on average from the time that they first received prescriptions for either an anxiolytic or hypnotic drug.

Benzodiazepines were the most commonly prescribed drug class, including diazepam and temazepam.

The study also examined the effects of two other groups of drugs; the so-called 'Z-drugs' and all other anxiolytic and hypnotic drugs.

Many patients received more than one drug over the course of the study, and five percent received prescriptions for drugs from all three groups.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 01 2014 | 2:54 PM IST

Next Story